- Investing Ideas
- /
- Global Small Cap High Growth Stocks
Global Small Cap High Growth Stocks
UPDATED Apr 19, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
2,431 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
HDG | ₫26,000.00 | -8.9% | 3.8% | ₫7.9t | ₫32,300.00 | PE12x | E31.4% | 0% | Capital Goods | ||
NEWBRY | kr3.50 | 3.6% | -36.4% | kr84.9m | kr8.00 | PS3.7x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
YGG | ฿7.70 | -2.5% | 6.9% | ฿4.6b | ฿10.75 | PE66.7x | E35.2% | 3.5% | Media | ||
688793 | CN¥31.88 | 1.5% | -3.2% | CN¥2.7b | CN¥35.60 | PS2.1x | E100.0% | 0% | Household | ||
688345 | CN¥19.12 | -10.3% | -49.2% | CN¥1.9b | n/a | PB1.6x | E92.0% | 2.1% | Capital Goods | ||
300700 | CN¥10.66 | -6.7% | -36.5% | CN¥3.0b | CN¥18.08 | PE26.4x | E40.2% | 1.2% | Capital Goods | ||
603173 | CN¥19.33 | -3.9% | -22.4% | CN¥3.1b | n/a | PE17.8x | E46.8% | 0.7% | Capital Goods | ||
5038 | JP¥1,369.00 | -3.7% | -36.0% | JP¥21.3b | n/a | PE33.5x | E24.7% | n/a | Healthcare | ||
A036200 | ₩11,710.00 | 24.8% | 46.9% | ₩349.9b | ₩13,000.00 | PE19.2x | E39.8% | 0.7% | Semiconductors | ||
A204620 | ₩6,990.00 | 1.7% | 95.3% | ₩396.9b | ₩10,333.33 | PS4.3x | E63.0% | n/a | Commercial Services | ||
A108860 | ₩16,310.00 | -4.1% | -18.9% | ₩439.0b | n/a | PS8.3x | E98.9% | n/a | Software | ||
3DA | AU$0.42 | 1.2% | 189.7% | AU$221.9m | n/a | PS271x | E80.5% | n/a | Capital Goods | ||
7373 | JP¥1,617.00 | -3.8% | -47.8% | JP¥24.4b | JP¥4,600.00 | PE21.7x | E28.1% | n/a | Commercial Services | ||
A254490 | ₩19,140.00 | -5.0% | -29.1% | ₩276.3b | n/a | PE54.6x | E75.7% | n/a | Tech | ||
517522 | ₹661.45 | 2.4% | -20.6% | ₹34.0b | ₹872.25 | PE46.7x | E39.5% | 0.3% | Materials | ||
RCEL | US$8.64 | -12.6% | -39.6% | US$228.8m | US$26.08 | PS4.4x | E62.9% | n/a | Pharmaceuticals & Biotech | ||
GTHX | US$4.11 | -9.7% | 52.2% | US$217.7m | US$8.50 | PS2.6x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$4.52 | -5.8% | -22.9% | US$188.3m | US$19.00 | PS6.9x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
IRISDOREME | ₹77.75 | -2.9% | 8.4% | ₹6.4b | ₹101.00 | PE57.9x | E51.4% | n/a | Consumer Durables | ||
A211050 | ₩4,900.00 | 0% | 125.8% | ₩241.6b | ₩3,800.00 | PE8.2x | E41.8% | 1.4% | Insurance | ||
A439090 | ₩19,060.00 | -1.2% | n/a | ₩312.2b | n/a | PE26.8x | E49.6% | n/a | Household | ||
CAI | AU$0.13 | 4.0% | -42.2% | AU$95.1m | n/a | PB0.7x | E110.6% | n/a | Materials | ||
CYC | AU$1.78 | -0.3% | -11.4% | AU$167.7m | AU$4.62 | PS6.2x | E92.8% | 0% | Healthcare | ||
HHR | AU$0.007 | 0% | -80.6% | AU$22.5m | n/a | PE6.7x | E86.3% | n/a | Energy |